Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      2744. A 5-Year Single-Center Review of Strongyloides Seropositivity in Kidney Transplant Candidates in Rural Central Texas

      abstract

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The American Society of Transplantation recommends screening for Strongyloides stercoralis for people from or with extended travel to endemic areas including tropical regions of Southeast Asia and the Appalachian region of the United States. Asymptomatic carriers without risk factors can potentially be missed during screening assessments. Consequently, they can develop deadly hyperinfection and disseminated disease with immunosuppressive therapy. The aim of this study is to identify demographics and characteristics among our population of Strongyloides-infected kidney transplant candidates in rural Central Texas.

          Methods

          This study is a single-center, retrospective chart review of patients aged 18 or older who underwent evaluation for kidney transplant at our institution in rural Central Texas between January 1, 2018 and December 31, 2022 and tested equivocal or positive for serum Strongyloides IgG antibody.

          Results

          Out of the 1653 patients who underwent Strongyloides screening during their evaluation for kidney transplant within the study period, 182 (11.0%) returned as either equivocal or positive. Demographics of this Strongyloides-infected population are noted in table 1. 86.3% of these patients were born in the United States or Canada, 6.6% from Mexico, and 3.3% from Asia. 33.0% reported no international travel outside the United States (table 1). Comorbidities and symptoms of our population are listed in table 2. 83.5% were asymptomatic. Laboratory data and other risk factors for Strongyloides infection are noted in table 3. Only 6.0% had eosinophilia at time of diagnosis (considered as greater than 0.00 - 0.76 10*9/L). None of our population tested positive for human T-lymphotrophic virus (HTLV-1). Out of the 69 patients who were asked, 71.0% reported a history of walking outside barefoot.

          Demographic information and international travel outside the United States

          Patient comorbidities and symptoms

          Laboratory data and other risk factors

          Conclusion

          Importantly, 11.0% of our population were found to have an equivocal or positive Strongyloides serology. Of those, 33.0% had no apparent risk factors for Strongyloides infection including international travel, suggesting local acquisition of the infection in rural Central Texas. More research is needed to identify unique risk factors for this population including environmental studies of this underserved population.

          Disclosures

          All Authors: No reported disclosures

          Related collections

          Author and article information

          Contributors
          Journal
          Open Forum Infect Dis
          Open Forum Infect Dis
          ofid
          Open Forum Infectious Diseases
          Oxford University Press (US )
          2328-8957
          December 2023
          27 November 2023
          27 November 2023
          : 10
          : Suppl 2 , IDWeek 2023 Abstracts
          : ofad500.2355
          Affiliations
          Baylor Scott & White Medical Center , Temple, Texas
          Baylor Scott & White Medical Center , Temple, Texas
          Baylor Scott and White Hospital , Temple, Texas
          Baylor Scott & White Medical Center , Temple, Texas
          University of Michigan , Ann Arbor, Michigan
          Author notes

          Session: 247. Transplant: Studies of Pre-Transplant Screening and Evaluation

          Saturday, October 14, 2023: 12:15 PM

          Article
          ofad500.2355
          10.1093/ofid/ofad500.2355
          10677149
          285864a1-6a79-4b09-952e-599ad16f5f35
          © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

          This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

          History
          Categories
          Abstract
          AcademicSubjects/MED00290

          Comments

          Comment on this article